All news

Search results (7)

Gynaecologic malignancies

18 Jun 2022

Lenvatinib plus pembrolizumab delays the time to deterioration of quality of life

Read more

Gynaecologic malignancies

18 Jun 2022

What is the state of play for molecular profiling in gynaecological malignancies?

Read more

17 Jun 2022

Recent advances fuelled by translational research reflect a greater focus on patients’ quality of life

The advent of PARP inhibitors, an increased use of laparoscopy for patient selection and a more prominent role of PROs have been facilitated by international collaborations

By Eric Pujade-Lauraine

Read more

Personalised medicine

17 Jun 2022

Is molecular profiling for gynaecological cancers worth the cost?

By
• Giovanni Scambia - Guest editor

Read more

Gynaecologic malignancies

17 Jun 2022

How to improve cervical cancer screening in low- or middle-income countries?

Read more

Gynaecologic malignancies

17 Jun 2022

Managing ovarian cancer in the PARP inhibitor era

Read more

17 May 2022

ESMO Gynae Cancers 2022 - What you can expect from this event

Watch video